This site has not been optimised for Internet Explorer due to Microsoft no longer providing support for the browser. Please view this site using another browser such as Google Chrome or Microsoft Edge.

About the programme


1. BMJ 2015

2. Clayton JM, Hancock KM, Butow PN, et al. 2007. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in advanced stages of a life-limiting illness, and their caregivers. MJA Supplement 186: 12.

3. Bernacki RE, Block SD. 2014. Communication about serious illness care goals – a review and synthesis of best practices. JAMA Intern Med Doi:10:1001.

4. Wright AA, Mack JW, Kritek PA, et al. 2010. Influence of patients’ preferences and treatment site on cancer patients’ end-of-life care. Cancer 116: 4656-63; Detering KM, Hancock AD, Reade MC, et al. 2010. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 340:c1345; Temel JS, Greeer JA, Muzikansky A, et al. 2010, Early palliative care for patients with metastatic non-small-cell lung cancer. N Eng J Med 363: 733-42.

5. Ariadne Labs is an American non-profit organisation lead by Atul Gawande (author of Being Mortal). 

6. Paladino J, Bernacki R, Neville BA, et al. 2019. Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program. JAMA Oncol doi:10.1001/jamaoncol.2019.0292.

7. Bernaki R, Paladino J, Neville BA, et al. 2019. Effect of the Serious Illness Care Program in Outpatient Oncology – a cluster randomized clinical trial. JAMA Intern Med Doi:10.1001.

Last updated: 25th November, 2021